%0 Journal Article %T Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism %A Qian Zhang %A Xinhua Xiao %A Kai Feng %A Tong Wang %A Wenhui Li %A Tao Yuan %A Xiaofang Sun %A Qi Sun %A Hongding Xiang %A Heng Wang %J Evidence-Based Complementary and Alternative Medicine %D 2011 %I Hindawi Publishing Corporation %R 10.1155/2011/924851 %X Berberine is known to improve glucose and lipid metabolism disorders, but the mechanism is still under investigation. In this paper, we explored the effects of berberine on the weight, glucose levels, lipid metabolism, and serum insulin of KKAy mice and investigated its possible glucose and lipid-regulating mechanism. We randomly divided KKAy mice into two groups: berberine group (treated with 250 mg/kg/d berberine) and control group. Fasting blood glucose (FBG), weight, total cholesterol (TC), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-c), low-density lipoprotein-cholesterol (LDL-c), and fasting serum insulin were measured in both groups. The oral glucose tolerance test (OGTT) was performed. RT2 PCR array gene expression analysis was performed using skeletal muscle of KKAy mice. Our data demonstrated that berberine significantly decreased FBG, area under the curve (AUC), fasting serum insulin (FINS), homeostasis model assessment insulin resistance (HOMA-IR) index, TC, and TG, compared with those of control group. RT2 profiler PCR array analysis showed that berberine upregulated the expression of glucose transporter 4 (GLUT4), mitogen-activated protein kinase 14 (MAPK14), MAPK8(c-jun N-terminal kinase, JNK), peroxisome proliferator-activated receptor (PPAR), uncoupling protein 2 (UCP2), and hepatic nuclear factor 4(HNF4), whereas it downregulated the expression of PPAR, CCAAT/enhancer-binding protein (CEBP), PPAR coactivator 1(PGC 1), and resistin. These results suggest that berberine moderates glucose and lipid metabolism through a multipathway mechanism that includes AMP-activated protein kinase-(AMPK-) p38 MAPK-GLUT4, JNK pathway, and PPAR pathway. %U http://www.hindawi.com/journals/ecam/2011/924851/